Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | IOVAIovance Biotherapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $263.50M |
| Revenue, yoy | +60.6% |
| Net income | $390.98M |
| Net income, yoy | −5.1% |
| Net margin | -148.4% |
| Free cash flow | $336.24M |
| FCF margin | -127.6% |
| EPS, diluted | $1.09 |
Add another company.